INCLISIRAN Solution for Injection
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Southern Health and Social Care Trust has issued a direct award contract to Novartis Pharmaceuticals UK Limited for the supply of Inclisiran solution for infusion. This agreement, identified by solicitation number L-DAC_1126/140, is valued at 400,000 pounds excluding VAT. The direct award was justified based on the supplier's exclusive intellectual property rights over the medication. The contract spans a three-year duration, officially commencing on November 11, 2026, and concluding on November 10, 2029. The award notice was formally posted on October 23, 2026, ensuring the continued availability of this specific injection solution for the Trust's healthcare requirements.
General Info
Documents
1AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
